Tag: Gastroenterology

Your Lifestyle Choices Could Be Causing Gastric Cancer

  <br> Gastric cancer occurs when healthy  stomach cells begin to grow  uncontrollably.  It develops slowly over the years and  can spread to the liver, lungs, and  bones.  The most common type is adenocarcinoma,  accounting for 95% of cases.  Other rare types include carcinoid  tumors and lymphas.  Every year around 28,000 people in the  US are diagnosed with gastric cancer.  The majority of cases are in individuals  over 65 with men being more affected  than women.  The incidence has decreased since the  1930s, possibly due to dietary changes  and better food preservation.  A significant cause of gastric cancer is  the bacterium helicoacttor pylori H  pylori.  This bacterium leads to stomach ulcers  and inflammation.  It can be treated with antibiotics,  making detection critical, especially  for those with a family history of the  disease.<br><br> Risk factors include a family history of  gastric cancer, previous stomach  surgery, and certain medical conditions  like pernicious anemia.  Lifestyle choices also impact risk.  A diet high in smoked or salted foods  and low in fruits and vegetables  increases susceptibility.  Additionally, smoking, heavy alcohol  consumption, and obesity are significant  lifestyle risks.  Symptoms of gastric cancer can be subtle  and may not appear early.  Key signs to watch for a persistent  tiredness, bloating after meals, painful  heartburn, nausea, and unexplained  weight loss.  Diagnosis begins with a doctor&#39;s  evaluation of symptoms and medical  history.  If gastric cancer is suspected, tests  will follow.  An endoscopy, a procedure using a small  camera, allows doctors to examine the  stomach.  If necessary, a biopsy will confirm the  presence of cancer cells.  Other diagnostic tests may include CT  scans for detailed imaging or MRIs that  use powerful magnets to create  comprehensive visuals.<br><br> Treatment typically starts with surgery  to remove tumors.  Depending on the stage and location,  part or all of the stomach may be  removed alongside nearby lymph nodes.  Radiation therapy or chemotherapy may  follow to eliminate remaining cancer  cells.  These treatments are often combined for  better effectiveness.  Targeted therapies aim at cancer cells  while sparing healthy tissue. While  imunotherapy enhances the body&#39;s  defenses against cancer.  For those interested in cuttingedge  options, clinical trials exploring new  treatments may be available.  Discussing these with your doctor can be  an important part of your healthcare  journey.  Understanding gastric cancer&#39;s causes,  symptoms, and treatment is vital for  early detection and effective  management.  Don&#39;t hesitate to consult your doctor  for advice or testing if you have  concerns.  Your health matters.. <br><br><a href="https://www.youtube.com/watch?v=Vhbv3DPtiAs" target="_blank">As found on YouTube</a>

24/12/2025

How Scientists Are Fighting Ulcerative Colitis Today

  <br> Are you or someone you know dealing with  ulcerative colitis?  Understanding this condition can be  overwhelming.  However, recent advancements in  treatment offer hope.  Ulcerative colitis is a form of  inflammatory bowel disease IBD.  It primarily causes inflammation in the  colon.  Symptoms can vary but often include  abdominal pain and diarrhea.  Various treatments exist, but  researchers are constantly searching for  better options.  Recent studies highlight some promising  developments.  One significant finding shows that using  two immunosuppressant drugs together is  more effective.  In a study, 83% of participants  experienced reduced inflammation when  treated with both glymab and gulkumab.  Comparatively, only 61% and 75% found  relief with each drug alone.  New research is also focusing on  genetics.  Identifying specific genes linked to  ulcerative colitis could lead to novel  treatment options that target these  genes directly.  The role of gut bacteria is gaining  attention, too.  Studies suggest that restoring a healthy  bacteria balance may improve treatment  outcomes.  Understanding which bacteria are harmful  or beneficial is vital.  Cytoines, substances affecting  inflammation, are crucial in ulcerative  colitis.  Future developments may include  personalized treatment plans based on an  individual&#39;s cytoine profile.  This could boost treatment efficacy.<br><br> Researchers are exploring interlucan 22,  a cytoine interfering with several body  processes related to ulcerative colitis.  Targeting this cytoine could lead to new  treatment breakthroughs.  A protein called is also under  investigation.  Higher levels of this protein are linked  to severe cases.  Blocking OPA has shown promise in  preclinical models.  Fecal transplants which involve  transferring stool from healthy donors  show potential.  This method may introduce beneficial gut  bacteria to those with ulcerative  colitis.  Interestingly, traditional remedies like  shamlan pills from eastern medicine are  showing early promise too.  Animal studies suggest these may help  reduce disease severity.  Lastly, a new drug, Etrazomod, is  showing favorable results in clinical  trials.<br><br> This medication may keep immune cells  from damaging the colon lining, offering  a path to remission for many.  These advancements provide hope and new  options for those affected by ulcerative  colitis.  Stay informed, discuss with health care  providers, and consider how these  treatments may benefit you or your loved  ones.. <br><br><a href="https://www.youtube.com/watch?v=4DJ11fdLszY" target="_blank">As found on YouTube</a>